In a Phase II clinical trial, retinal transplantation is being tested in patients with retinitis pigmentosa or dry age-related macular degeneration.
Retinal transplantation refers to the placement of sheets of developing retinal and retinal pigment epithelial(RPE) cells into the subretinal space. Preclinical studies and a positive outcome in a single patient have indicated that it may be possible to enhance retinal function through transplantation of healthy cells in patients with low or no vision. The research is being led by Dr. Norman D. Radtke of Louisville, Kentucky.
To participate a person must be at least 21 years of age, have no diabetes or glaucoma, and have vision of 20/200 or worse in one eye. The transplant is in that one eye only. Pregnancy rules out eligibility.
Patients will be required to travel to Louisville Kentucky for tests and examination during the pre- and post-operative period. Testing and surgical expenses will be covered. Anyone interested in more information should use the following contact information:
Ms. Mary HilliardCreated on ... January 23, 2007